Meek M E, Boobis A, Cote I, Dellarco V, Fotakis G, Munn S, Seed J, Vickers C
Chemical Risk Assessment, McLaughlin Centre for Population Health Risk Assessment, 1 Stewart Street, Ottawa, Ontario, Canada, K1N 6N5.
J Appl Toxicol. 2014 Jan;34(1):1-18. doi: 10.1002/jat.2949. Epub 2013 Oct 25.
The World Health Organization/International Programme on Chemical Safety mode of action/human relevance framework has been updated to reflect the experience acquired in its application and extend its utility to emerging areas in toxicity testing and non-testing methods. The underlying principles have not changed, but the framework's scope has been extended to enable integration of information at different levels of biological organization and reflect evolving experience in a much broader range of potential applications. Mode of action/species concordance analysis can also inform hypothesis-based data generation and research priorities in support of risk assessment. The modified framework is incorporated within a roadmap, with feedback loops encouraging continuous refinement of fit-for-purpose testing strategies and risk assessment. Important in this construct is consideration of dose-response relationships and species concordance analysis in weight of evidence. The modified Bradford Hill considerations have been updated and additionally articulated to reflect increasing experience in application for cases where the toxicological outcome of chemical exposure is known. The modified framework can be used as originally intended, where the toxicological effects of chemical exposure are known, or in hypothesizing effects resulting from chemical exposure, using information on putative key events in established modes of action from appropriate in vitro or in silico systems and other lines of evidence. This modified mode of action framework and accompanying roadmap and case examples are expected to contribute to improving transparency in explicitly addressing weight of evidence considerations in mode of action/species concordance analysis based on both conventional data sources and evolving methods.
世界卫生组织/国际化学品安全规划署的作用机制/人体相关性框架已更新,以反映其应用过程中积累的经验,并将其效用扩展到毒性测试和非测试方法的新兴领域。基本原则未变,但框架的范围已扩大,以便能够整合不同生物组织层面的信息,并反映在更广泛潜在应用中的不断发展的经验。作用机制/物种一致性分析还可为基于假设的数据生成和支持风险评估的研究重点提供信息。修改后的框架被纳入一个路线图中,通过反馈回路鼓励不断完善适用的测试策略和风险评估。在此架构中,重要的是在证据权重中考虑剂量反应关系和物种一致性分析。修改后的布拉德福德·希尔考量因素已更新并进一步阐述,以反映在已知化学物质暴露毒理学结果的案例应用中不断增加的经验。修改后的框架可按其最初意图使用,即在已知化学物质暴露的毒理学效应时,或在假设化学物质暴露产生的效应时,利用来自适当体外或计算机模拟系统的既定作用机制中假定关键事件的信息及其他证据线索。预计这种修改后的作用机制框架以及附带的路线图和案例示例将有助于提高透明度,以便在基于传统数据源和不断发展的方法进行作用机制/物种一致性分析时,明确考虑证据权重。